Navigation Links
Arctic Sun Again Preferred Choice of Top-Ranked U.S. Hospitals for Therapeutic Temperature Management

LOUISVILLE, Colo., Sept. 9 /PRNewswire/ -- The number of Arctic Sun(R) users among hospitals ranked top 20 jumped to 90 percent this year from 72 percent last year, Medivance announced today. All top 10 "best hospitals" prefer the ease and safety of its advanced non-invasive method for rapid, controlled temperature reduction followed by slow rewarming.

The potential rewards of therapeutic temperature management -- the satisfaction of seeing critically ill patients return to their previous lives by protecting them from brain damage -- are so great that 90 percent of U.S. hospitals ranked the nation's best by US News and World Report cool patients therapeutically with the Arctic Sun.

"Therapeutic temperature management is here to stay. It gives patients the best chance of full recovery," said Daniel L. Herr, MD, editor of the July 2009 Critical Care Medicine journal supplement on the topic. Washington Hospital Center, where he is Medical Director of the Surgical Intensive Care Unit, ranked among the top 20 heart programs.

"Technological advances in critical care medicine are always aiming at improving outcomes with minimum risk. Such balance is well demonstrated with the institution of temperature modulation (hypothermia) following cardiac arrest as well as other paradigms of acute brain injury," said J. Ricardo Carhuapoma, MD, of the Division of Neurosciences Critical Care at Johns Hopkins Hospital, which ranked top overall and second in neurology.

"The use of Medivance's Arctic Sun has provided the field of Neurosciences Critical Care with a powerful tool to help with the treatment of complex and highly vulnerable patients," he added.

Cooling: effective and cost-effective

Cooling cardiac arrest survivors is as cost effective as other widely accepted treatments and can increase survival, according to a report published in the current issue of the journal Circulation: Cardiovascular Quality and Outcomes.

"The choice of the Arctic Sun by hospitals ranked best in the nation is in keeping with the three major trends in medicine today -- improving outcomes, avoiding unnecessary complications and reducing healthcare costs," said Robert Kline, Medivance's CEO.

Cooling a standard of care

Since 2005, when the American Heart Association (AHA) issued recommendations and guidelines for inducing mild hypothermia in comatose survivors of cardiac arrest, adoption of therapeutic cooling has been on the rise. A rapidly growing body of medical literature suggests it may also reduce damage resulting from refractory fevers and other critical illnesses such as stroke.

About Medivance's Arctic Sun

The non-invasive Arctic Sun Temperature Management System precisely monitors and maintains core body temperature in a therapeutic range, between 32 degrees and 38.5 degrees Celsius (approximately 89.6 degrees to 101.3 degrees Fahrenheit) with the potential to minimize damage to the heart and brain. The patented design of the Arctic Sun and ArcticGel(TM) Pads enables them to transfer up to five times more thermal energy than conventional products such as water blankets, wraps or ice packs, resulting in more efficient temperature management. The system's precision also enables the slow rewarming thought to be critical for therapeutic benefit. The Arctic Sun has received 510(k) FDA clearance in the U.S., the European Union's CE Mark, and marketing approval in Japan and other global markets. Medivance develops and manufactures non-invasive, proprietary therapeutic temperature management solutions.

SOURCE Medivance
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. African seed collection first to arrive in Norway on route to Arctic seed vault
2. Hibernation-like behavior in Antarctic fish -- on ice for winter
3. More than Seventy Percent of Top US Hospitals Control Patient Temperature with High-Tech Arctic Sun(TM)
4. CryoCath Introduces Arctic Front in Australia
5. Arctic explorer delivers unique snow-depth data for CryoSat
6. UAF to host Eighth Conference of Arctic Parliamentarians
7. Top Heart Programs Choose Safety of Medivances Non-Invasive Arctic Sun(R) for Therapeutic Hypothermia
8. Remote Medicine: GWU Medical Faculty Treat Antarctica Personnel
9. 56-Year-Old Grandmother Heads to Antarctica to Run Her Seventh Worldwide Marathon in Under a Year
10. Top Neurology Programs Control Fever with Arctic Sun Cooling Technology
11. DNA vaccine against multiple sclerosis appears safe, potentially beneficial
Post Your Comments:
(Date:12/1/2015)... , ... December 01, 2015 , ... Califia Farms ... announced that its iconic bottle has won top honors in Beverage World Magazine’s Global ... Company also announced that it has been selected as a 2015 U.S.A. Taste Champion ...
(Date:12/1/2015)... MD (PRWEB) , ... December 01, 2015 , ... ... salmon identification tests to continue the expansion of the company’s growing product line ... – for Chinook (Oncorhynchus tshawytscha) and Sockeye (Oncorhynchus nerka) – allow InstantLabs to ...
(Date:12/1/2015)... ... December 01, 2015 , ... The ... been lifted as IMAGE Information Systems launches MED-TAB™ -- the world’s first portable ... Meeting from November 29 to December 4, 2015. , MED-TAB is expected ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... is everything. That is why Hollister Incorporated has launched the VaPro Plus Pocket™ ... next product in the VaPro touch free catheter portfolio,” said Michael Gresavage, Vice ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... today announced it has been awarded a fixed price per sprint agile development ... contract, valued at $34 million over five years, provides software engineering, infrastructure, as ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 1, 2015 --> ... Drugs Market by Type of Drug (Monoclonal Antibodies, Interferon-Alpha, Interleukins, ... and Pipeline Analysis - Global Forecast to 2020", published by ... USD 73,529.2 Million by 2020 from USD 40,281.6 Million in ... Browse 37 market data ...
(Date:12/1/2015)... BANGALORE, India and PITTSBURGH ... TASE: MYL) today announced that it expects to be ... developing country markets funded by international donors, TLE400 (Tenofovir ... Efavirenz 400 mg) for $99 per patient, per year. ... to develop TLE400. The significantly reduced price could generate ...
(Date:12/1/2015)... , Dec. 1, 2015  AccuTEC Blades, a ... new corporate logo and brand identity program. The ... and engineering of bladed products where "the edge ... --> Serving manufacturers and distributors ... auto glass equipment, AccuTEC,s product lines include those ...
Breaking Medicine Technology: